Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Ann Intern Med
    March 2024
  1. MUKHERJEE D
    In acute MI and anemia, restrictive vs. liberal transfusion did not differ for a composite of recurrent MI or death at 30 d.
    Ann Intern Med. 2024 Mar 5. doi: 10.7326/J24-0010.
    >> Share

    February 2024
  2. BASU A, Winn AN, Johnson KM, Jiao B, et al
    Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.
    Ann Intern Med. 2024;177:155-164.
    >> Share

    January 2024
  3. WESEVICH A, Peek ME, Ratain MJ
    An Ethical and Financial Obligation for Sickle Cell Disease Gene Therapy in the United States.
    Ann Intern Med. 2024;177:85-86.
    >> Share

    October 2023
  4. CARLIN S, Eikelboom JW
    In healthy older adults, low-dose aspirin increased incident anemia at a median 4.7 y.
    Ann Intern Med. 2023 Oct 3. doi: 10.7326/J23-0075.
    >> Share

    September 2023
  5. CENTOR RM, McQuilten ZK
    Web Exclusive. Annals On Call - Low-Dose Aspirin and Iron Deficiency Anemia.
    Ann Intern Med. 2023;176:eA220018.
    >> Share

    July 2023

  6. Correction: Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly.
    Ann Intern Med. 2023 Jul 25. doi: 10.7326/L23-0274.
    >> Share

    June 2023
  7. MCQUILTEN ZK, Thao LTP, Pasricha SR, Artz AS, et al
    Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly : A Secondary Analysis of the Aspirin in Reducing Events in the Elderly Trial.
    Ann Intern Med. 2023 Jun 20. doi: 10.7326/M23-0675.
    >> Share

  8. GOSHUA G, Calhoun C, Ito S, James LP, et al
    Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States.
    Ann Intern Med. 2023;176:779-787.
    >> Share

    April 2023
  9. LERMAN JB, Newby LK
    In HF with iron deficiency, IV ferric derisomaltose was associated with lower rates of HF hospitalization or CV death.
    Ann Intern Med. 2023;176:JC40.
    >> Share

    August 2022
  10. BANNOW BS
    In older adults, iron dextran and ferumoxytol each had higher anaphylaxis risk at
    Ann Intern Med. 2022;175:JC95.
    >> Share

    April 2022
  11. KANJEE Z, Achebe MO, Smith WR, Burns RB, et al
    How Would You Treat This Patient With Acute and Chronic Pain From Sickle Cell Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2022 Apr 12. doi: 10.7326/M22-0038.
    >> Share

    October 2021
  12. DONATO AA, Green J
    In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wk.
    Ann Intern Med. 2021;174:JC110.
    >> Share

    September 2021
  13. KANTER J
    One Small Step for Sickle Cell Disease: Many More to Go.
    Ann Intern Med. 2021;174:1313-1314.
    >> Share

    July 2021
  14. CLIFT AK, Saatci D, Coupland CAC, Dambha-Miller H, et al
    Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M21-1375.
    >> Share

  15. JIANG D, Garcia D
    In patients with AMI and anemia, a restrictive vs. liberal blood transfusion strategy was noninferior for 30-d MACE.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    >> Share


  16. Summary for Patients: Treating Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/P21-0005.
    >> Share

  17. LANZKRON S, Little J, Wang H, Field JJ, et al
    Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/M20-7171.
    >> Share

  18. LACOMBE V, Kosmider O, Prevost M, Lavigne C, et al
    Severe Joint Involvement in VEXAS Syndrome: A Case Report.
    Ann Intern Med. 2021;174:1025-1027.
    >> Share

  19. DESAI P, Little J, Kanter J, Bridges K, et al
    Kneeling Was the First Step for Sickle Cell Disease.
    Ann Intern Med. 2021;174:1004-1005.
    >> Share

    April 2021
  20. DEFILIPPIS EM, Van Spall HGC
    In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y.
    Ann Intern Med. 2021;174:JC45.
    >> Share

    January 2021
  21. PECKER LH, Lanzkron S
    Sickle Cell Disease.
    Ann Intern Med. 2021;174:ITC1-ITC16.
    >> Share

    December 2020
  22. FAUGHNAN ME, Mager JJ, Hetts SW, Palda VA, et al
    Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.
    Ann Intern Med. 2020;173:989-1001.
    >> Share

    November 2020
  23. SCHIAVON CA, Bhatt DL, Ikeoka D, Santucci EV, et al
    Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension : A Randomized Clinical Trial.
    Ann Intern Med. 2020;173:685-693.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016